Antimicrobial peptides: an alternative for innovative medicines?
about
Design and Application of Antimicrobial Peptide ConjugatesLongipin: An Amyloid Antimicrobial Peptide from the Harvestman Acutisoma longipes (Arachnida: Opiliones) with Preferential Affinity for Anionic VesiclesProspects of In vivo Incorporation of Non-canonical Amino Acids for the Chemical Diversification of Antimicrobial PeptidesRole of Pattern Recognition Receptors in the Modulation of Antimicrobial Peptide Expression in the Corneal Epithelial Innate Response to F. solani.S-thanatin functionalized liposome potentially targeting on Klebsiella pneumoniae and its application in sepsis mouse model.Marine Peptides: Bioactivities and ApplicationsInsight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics.Major Antimicrobial Representatives from Marine Sponges and/or Their Associated Bacteria.Dying blood mononuclear cell secretome exerts antimicrobial activity.Natural and synthetic peptides with antifungal activity.Lysine-Based α-Peptide/β-Peptoid Peptidomimetics: Influence of Hydrophobicity, Fluorination, and Distribution of Cationic Charge on Antimicrobial Activity and Cytotoxicity.Tryptophan-Containing Cyclic Decapeptides with Activity against Plant Pathogenic Bacteria.Salivary proteomics of healthy dogs: An in depth catalog.Production of an anti-Candida peptide via fed batch and ion exchange chromatography.NKCS, a Mutant of the NK-2 Peptide, Causes Severe Distortions and Perforations in Bacterial, But Not Human Model Lipid Membranes.Expression of a recombinant hybrid antimicrobial peptide magainin II-cecropin B in the mycelium of the medicinal fungus Cordyceps militaris and its validation in mice.Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin.Adding Functions to Biomaterial Surfaces through Protein Incorporation.Expression of plectasin in Bacillus subtilis using SUMO technology by a maltose-inducible vector.Antimicrobial Peptides and Nanotechnology, Recent Advances and Challenges.Antimicrobial Peptides: Interaction With Model and Biological Membranes and Synergism With Chemical Antibiotics.Exploring the role of unnatural amino acids in antimicrobial peptides.Evaluation of an Improved Chitosan Scaffold Cross-Linked With Polyvinyl Alcohol and Amine Coupling Through 1-Ethyl-3-(3-Dimethyl Aminopropyl)-Carbodiimide (EDC) and 2 N-Hydroxysuccinimide (NHS) for Corneal Applications
P2860
Q26749068-83DB7482-6D31-4320-A2AE-001F99867FB5Q28555126-FBC330FC-BFF0-4485-8E48-4A1A7E1DC3ABQ28817674-450C45E0-3176-44E7-841E-6CFEDCB707CCQ33626993-E3427962-5927-4719-AF08-70D22F4B3C6BQ35844672-58BE444C-3309-4556-8DD3-3783C18E93E6Q35890691-C888E9AC-332C-4B4F-B5C6-292F2F588138Q35948339-3ACFBD6D-D37A-4B72-9F4A-3B05AA3255A1Q36290887-E194BD92-F5B0-4595-8AF2-0E820B20275BQ37420535-DA6FEAFE-32E6-41CB-8C17-E57DC4FCDFDBQ38833324-BEC03947-7B85-4B04-AE89-99E95143F3F8Q42804043-D6EEB4B7-3430-4CDF-89E1-B5AA0CD8598BQ47714243-CDB5D20E-A87E-4647-BDF5-425558E0EF0EQ47735191-217473DB-1551-4518-9482-6BD5E2DC1EFFQ47802195-FB4BE181-1995-4461-A1A0-D0E560129B3EQ48672888-937E809F-CFAB-46C9-B898-3154398742FCQ49267902-C1DD83F1-220C-4F91-B975-A2E94A383604Q51318320-0627EC8F-FC44-49CA-932B-3186371F7781Q53100671-89C6C2FE-9A6A-45D5-95BC-921BED479E89Q54261886-79554949-1355-4FD9-A2DF-49697BACCF52Q55053689-C58341C2-FC43-4611-A5B9-DA8E8C1D4C5DQ55252918-C30D4A2C-631E-46F1-8CB0-60040A764E74Q55288780-025CD43B-7390-4B80-A5F8-591AA1E3BB9FQ58554148-669FC564-76B1-4C43-AE27-0E29B8AC6AF1
P2860
Antimicrobial peptides: an alternative for innovative medicines?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Antimicrobial peptides: an alternative for innovative medicines?
@en
type
label
Antimicrobial peptides: an alternative for innovative medicines?
@en
prefLabel
Antimicrobial peptides: an alternative for innovative medicines?
@en
P2860
P50
P1476
Antimicrobial peptides: an alternative for innovative medicines?
@en
P2093
João Pinto da Costa
P2860
P2888
P304
P356
10.1007/S00253-015-6375-X
P407
P577
2015-01-15T00:00:00Z
P6179
1000203781